메뉴 건너뛰기
Journal of Virology
Volumn 89, Issue 11, 2015, Pages 5760-5771
Early kinetics of the HLA class I-associated peptidome of MVA.HIV consv-infected cells
Author keywords

[No Author keywords available]
Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS PROTEIN; VIRUS VECTOR; PEPTIDE; RECOMBINANT VACCINE; VIRUS ANTIGEN;
EID: 84929629128     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03627-14     Document Type: Article
Times cited : (31)
References (68)
  • 1
    • 0021212018 scopus 로고
    • Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen
    • Shimonkevitz R, Colon S, Kappler JW, Marrack P, Grey HM. 1984. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol 133:2067-2074.
    • (1984) J Immunol , vol.133 , pp. 2067-2074
    • Shimonkevitz, R.1    Colon, S.2    Kappler, J.W.3    Marrack, P.4    Grey, H.M.5
  • 2
    • 0022483534 scopus 로고
    • The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
    • Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-968. http://dx.doi.org/10.1016/0092-8674(86)90019-X.
    • (1986) Cell , vol.44 , pp. 959-968
    • Townsend, A.R.1    Rothbard, J.2    Gotch, F.M.3    Bahadur, G.4    Wraith, D.5    McMichael, A.J.6
  • 3
    • 0036301672 scopus 로고    scopus 로고
    • T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens
    • Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3:627-634. http://dx.doi.org/10.1038/ni806.
    • (2002) Nat Immunol , vol.3 , pp. 627-634
    • Brehm, M.A.1    Pinto, A.K.2    Daniels, K.A.3    Schneck, J.P.4    Welsh, R.M.5    Selin, L.K.6
  • 4
    • 33749528390 scopus 로고    scopus 로고
    • Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses
    • Yewdell JW. 2006. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25:533-543. http://dx.doi.org/10.1016/j.immuni.2006.09.005.
    • (2006) Immunity , vol.25 , pp. 533-543
    • Yewdell, J.W.1
  • 5
    • 0033046472 scopus 로고    scopus 로고
    • Immunodominance in major histocompatibility complex class I-restrictedTlymphocyte responses
    • Yewdell JW, Bennink JR. 1999. Immunodominance in major histocompatibility complex class I-restrictedTlymphocyte responses. AnnuRevImmunol 17:51-88. http://dx.doi.org/10.1146/annurev.immunol.17.1.51.
    • (1999) Annu Rev Immunol , vol.17 , pp. 51-88
    • Yewdell, J.W.1    Bennink, J.R.2
  • 7
    • 70649093803 scopus 로고    scopus 로고
    • Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development
    • Johnson KL, Ovsyannikova IG, Mason CJ, Bergen HR, III, Poland GA. 2009. Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. Vaccine 28:38-47. http://dx.doi.org/10.1016/j.vaccine.2009.09.126.
    • (2009) Vaccine , vol.28 , pp. 38-47
    • Johnson, K.L.1    Ovsyannikova, I.G.2    Mason, C.J.3    Bergen, H.R.4    Poland, G.A.5
  • 8
    • 71249121791 scopus 로고    scopus 로고
    • HLA class I molecules reflect an altered host proteome after influenza virus infection
    • Wahl A, Schafer F, Bardet W, Hildebrand WH. 2010. HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum Immunol 71:14-22. http://dx.doi.org/10.1016/j.humimm.2009.08.012.
    • (2010) Hum Immunol , vol.71 , pp. 14-22
    • Wahl, A.1    Schafer, F.2    Bardet, W.3    Hildebrand, W.H.4
  • 13
    • 84898716225 scopus 로고    scopus 로고
    • Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines
    • Hanke T. 2014. Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines. Expert Opin Biol Ther 14:601-616. http://dx.doi.org/10.1517/14712598.2014.885946.
    • (2014) Expert Opin Biol Ther , vol.14 , pp. 601-616
    • Hanke, T.1
  • 14
    • 44049108744 scopus 로고    scopus 로고
    • Toward an AIDS vaccine
    • Walker BD, Burton DR. 2008. Toward an AIDS vaccine. Science 320: 760-764. http://dx.doi.org/10.1126/science.1152622.
    • (2008) Science , vol.320 , pp. 760-764
    • Walker, B.D.1    Burton, D.R.2
  • 17
    • 84875546274 scopus 로고    scopus 로고
    • Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design
    • Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK. 2013. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38:606-617. http://dx.doi.org/10.1016/j.immuni.2012.11.022.
    • (2013) Immunity , vol.38 , pp. 606-617
    • Ferguson, A.L.1    Mann, J.K.2    Omarjee, S.3    Ndung'u, T.4    Walker, B.D.5    Chakraborty, A.K.6
  • 22
    • 84914692091 scopus 로고    scopus 로고
    • Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice
    • Ondondo B, Abdul-Jawad S, Bridgeman A, Hanke T. 2014. Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice. Clin Vaccine Immunol 21:1565-1572. http://dx.doi.org/10.1128/CVI.00587-14.
    • (2014) Clin Vaccine Immunol , vol.21 , pp. 1565-1572
    • Ondondo, B.1    Abdul-Jawad, S.2    Bridgeman, A.3    Hanke, T.4
  • 25
    • 4344714042 scopus 로고    scopus 로고
    • MVA as a vector for vaccines against HIV-1
    • Im E-J, Hanke T. 2004. MVA as a vector for vaccines against HIV-1. Expert Rev Vaccines 3:S89-S97. http://dx.doi.org/10.1586/14760584.3.4.S89.
    • (2004) Expert Rev Vaccines , vol.3 , pp. S89-S97
    • Im, E.-J.1    Hanke, T.2
  • 26
    • 0016721708 scopus 로고
    • Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA
    • Mayr A, Hochstein-Mintzel V, Stickl H. 1975. Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 105:6-14.
    • (1975) Infection , vol.105 , pp. 6-14
    • Mayr, A.1    Hochstein-Mintzel, V.2    Stickl, H.3
  • 28
    • 33646449925 scopus 로고    scopus 로고
    • Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine
    • Dorrell L, Yang H, Ondondo B, Dong T, di Gleria K, Suttill A, Conlon C, Brown D, Williams P, Bowness P, Goonetilleke N, Rostron T, Rowland-Jones S, Hanke T, McMichael AJ. 2006. Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine. J Virol 80: 4705-4716. http://dx.doi.org/10.1128/JVI.80.10.4705-4716.2006.
    • (2006) J Virol , vol.80 , pp. 4705-4716
    • Dorrell, L.1    Yang, H.2    Ondondo, B.3    Dong, T.4    di Gleria, K.5    Suttill, A.6    Conlon, C.7    Brown, D.8    Williams, P.9    Bowness, P.10    Goonetilleke, N.11    Rostron, T.12    Rowland-Jones, S.13    Hanke, T.14    McMichael, A.J.15
  • 29
    • 33846148643 scopus 로고    scopus 로고
    • Clinical experience with plasmid DNA-and modified vaccinia vaccine Ankara (MVA)-vectored HIV-1 clade A vaccine inducing T cells
    • Hanke T, Goonetilleke N, McMichael AJ, Dorrell L. 2007. Clinical experience with plasmid DNA-and modified vaccinia vaccine Ankara (MVA)-vectored HIV-1 clade A vaccine inducing T cells. J Gen Virol 88:1-12. http://dx.doi.org/10.1099/vir.0.82493-0.
    • (2007) J Gen Virol , vol.88 , pp. 1-12
    • Hanke, T.1    Goonetilleke, N.2    McMichael, A.J.3    Dorrell, L.4
  • 30
    • 9144267735 scopus 로고    scopus 로고
    • Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
    • McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10:1240-1244. http://dx.doi.org/10.1038/nm1128.
    • (2004) Nat Med , vol.10 , pp. 1240-1244
    • McShane, H.1    Pathan, A.A.2    Sander, C.R.3    Keating, S.M.4    Gilbert, S.C.5    Huygen, K.6    Fletcher, H.A.7    Hill, A.V.8
  • 32
    • 84859826519 scopus 로고    scopus 로고
    • PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification
    • Zhang J, Xin L, Shan B, Chen W, Xie M, Yuen D, Zhang W, Zhang Z, Lajoie GA, Ma B. 2012. PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics 11:M111.010587. http://dx.doi.org/10.1074/mcp.M111.010587.
    • (2012) Mol Cell Proteomics , vol.11
    • Zhang, J.1    Xin, L.2    Shan, B.3    Chen, W.4    Xie, M.5    Yuen, D.6    Zhang, W.7    Zhang, Z.8    Lajoie, G.A.9    Ma, B.10
  • 33
    • 0028302652 scopus 로고
    • Expression and purification of nonglycosylated SIV proteins, and their use in induction and detection of SIV-specific immune responses
    • Hanke T, Botting C, Green EA, Szawlowski PW, Rud E, Randall RE. 1994. Expression and purification of nonglycosylated SIV proteins, and their use in induction and detection of SIV-specific immune responses. AIDS Res Hum Retroviruses 10:665-674. http://dx.doi.org/10.1089/aid.1994.10.665.
    • (1994) AIDS Res Hum Retroviruses , vol.10 , pp. 665-674
    • Hanke, T.1    Botting, C.2    Green, E.A.3    Szawlowski, P.W.4    Rud, E.5    Randall, R.E.6
  • 34
    • 84861325093 scopus 로고    scopus 로고
    • Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation
    • Guzman E, Cubillos-Zapata C, Cottingham MG, Gilbert SC, Prentice H, Charleston B, Hope JC. 2012. Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation. J Virol 86:5452-5466. http://dx.doi.org/10.1128/JVI.00264-12.
    • (2012) J Virol , vol.86 , pp. 5452-5466
    • Guzman, E.1    Cubillos-Zapata, C.2    Cottingham, M.G.3    Gilbert, S.C.4    Prentice, H.5    Charleston, B.6    Hope, J.C.7
  • 35
  • 36
    • 48449106045 scopus 로고    scopus 로고
    • NetMHC-3.0: accurate Web accessible predictions of human, mouse and monkeyMHCclass I affinities for peptides of length 8-11
    • Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. 2008. NetMHC-3.0: accurate Web accessible predictions of human, mouse and monkeyMHCclass I affinities for peptides of length 8-11. Nucleic Acids Res 36:W509-W512. http://dx.doi.org/10.1093/nar/gkn202.
    • (2008) Nucleic Acids Res , vol.36 , pp. W509-W512
    • Lundegaard, C.1    Lamberth, K.2    Harndahl, M.3    Buus, S.4    Lund, O.5    Nielsen, M.6
  • 37
    • 44349146151 scopus 로고    scopus 로고
    • Accurate approximation method for prediction of class IMHCaffinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers
    • Lundegaard C, Lund O, Nielsen M. 2008. Accurate approximation method for prediction of class IMHCaffinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24:1397-1398. http://dx.doi.org/10.1093/bioinformatics/btn128.
    • (2008) Bioinformatics , vol.24 , pp. 1397-1398
    • Lundegaard, C.1    Lund, O.2    Nielsen, M.3
  • 38
    • 0037407113 scopus 로고    scopus 로고
    • Reliable prediction of T-cell epitopes using neural networks with novel sequence representations
    • Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O. 2003. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12:1007-1017. http://dx.doi.org/10.1110/ps.0239403.
    • (2003) Protein Sci , vol.12 , pp. 1007-1017
    • Nielsen, M.1    Lundegaard, C.2    Worning, P.3    Lauemoller, S.L.4    Lamberth, K.5    Buus, S.6    Brunak, S.7    Lund, O.8
  • 39
    • 0029897044 scopus 로고    scopus 로고
    • Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
    • Sidney J, Grey HM, Kubo RT, Sette A. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 17:261-266. http://dx.doi.org/10.1016/0167-5699(96)80542-1.
    • (1996) Immunol Today , vol.17 , pp. 261-266
    • Sidney, J.1    Grey, H.M.2    Kubo, R.T.3    Sette, A.4
  • 41
    • 33749474469 scopus 로고    scopus 로고
    • Hitting HIV where it hurts: an alternative approach to HIV vaccine design
    • Altfeld M, Allen TM. 2006. Hitting HIV where it hurts: an alternative approach to HIV vaccine design. Trends Immunol 27:504-510. http://dx.doi.org/10.1016/j.it.2006.09.007.
    • (2006) Trends Immunol , vol.27 , pp. 504-510
    • Altfeld, M.1    Allen, T.M.2
  • 43
    • 37348999199 scopus 로고    scopus 로고
    • HIV-1 group M conserved elements vaccine
    • Rolland M, Nickle DC, Mullins JI. 2007. HIV-1 group M conserved elements vaccine. PLoS Pathog 3:e157. http://dx.doi.org/10.1371/journal.ppat.0030157.
    • (2007) PLoS Pathog , vol.3
    • Rolland, M.1    Nickle, D.C.2    Mullins, J.I.3
  • 44
    • 70349751687 scopus 로고    scopus 로고
    • Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners
    • Liu Y, Woodward A, Zhu H, Andrus T, McNevin J, Lee J, Mullins JI, Corey L, McElrath MJ, Zhu T. 2009. Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners. J Virol 83:10821-10829. http://dx.doi.org/10.1128/JVI.00839-09.
    • (2009) J Virol , vol.83 , pp. 10821-10829
    • Liu, Y.1    Woodward, A.2    Zhu, H.3    Andrus, T.4    McNevin, J.5    Lee, J.6    Mullins, J.I.7    Corey, L.8    McElrath, M.J.9    Zhu, T.10
  • 45
    • 50849112397 scopus 로고    scopus 로고
    • Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles
    • Gudmundsdotter L, Bernasconi D, Hejdeman B, Sandstrom E, Alaeus A, Lidman K, Ensoli B, Wahren B, Butto S. 2008. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles. Vaccine 26:5182-5187. http://dx.doi.org/10.1016/j.vaccine.2008.03.094.
    • (2008) Vaccine , vol.26 , pp. 5182-5187
    • Gudmundsdotter, L.1    Bernasconi, D.2    Hejdeman, B.3    Sandstrom, E.4    Alaeus, A.5    Lidman, K.6    Ensoli, B.7    Wahren, B.8    Butto, S.9
  • 46
    • 0032503233 scopus 로고    scopus 로고
    • The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses
    • Antoine G, Scheiflinger F, Dorner F, Falkner FG. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396. http://dx.doi.org/10.1006/viro.1998.9123.
    • (1998) Virology , vol.244 , pp. 365-396
    • Antoine, G.1    Scheiflinger, F.2    Dorner, F.3    Falkner, F.G.4
  • 47
    • 33846500919 scopus 로고    scopus 로고
    • Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules
    • Dasgupta A, Hammarlund E, Slifka MK, Fruh K. 2007. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J Immunol 178:1654-1661. http://dx.doi.org/10.4049/jimmunol.178.3.1654.
    • (2007) J Immunol , vol.178 , pp. 1654-1661
    • Dasgupta, A.1    Hammarlund, E.2    Slifka, M.K.3    Fruh, K.4
  • 48
    • 34548424032 scopus 로고    scopus 로고
    • Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination
    • Kastenmuller W, Gasteiger G, Gronau JH, Baier R, Ljapoci R, Busch DH, Drexler I. 2007. Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med 204: 2187-2198. http://dx.doi.org/10.1084/jem.20070489.
    • (2007) J Exp Med , vol.204 , pp. 2187-2198
    • Kastenmuller, W.1    Gasteiger, G.2    Gronau, J.H.3    Baier, R.4    Ljapoci, R.5    Busch, D.H.6    Drexler, I.7
  • 49
    • 42949155679 scopus 로고    scopus 로고
    • Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo
    • Liu L, Chavan R, Feinberg M. 2008. Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunol 9:15. http://dx.doi.org/10.1186/1471-2172-9-15.
    • (2008) BMC Immunol , vol.9 , pp. 15
    • Liu, L.1    Chavan, R.2    Feinberg, M.3
  • 50
    • 70349659930 scopus 로고    scopus 로고
    • Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II
    • Rehm KE, Connor RF, Jones GJ, Yimbu K, Mannie MD, Roper RL. 2009. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Immunology 128:381-392. http://dx.doi.org/10.1111/j.1365-2567.2009.03120.x.
    • (2009) Immunology , vol.128 , pp. 381-392
    • Rehm, K.E.1    Connor, R.F.2    Jones, G.J.3    Yimbu, K.4    Mannie, M.D.5    Roper, R.L.6
  • 51
    • 0024095276 scopus 로고
    • Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen
    • Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168:1211-1224. http://dx.doi.org/10.1084/jem.168.4.1211.
    • (1988) J Exp Med , vol.168 , pp. 1211-1224
    • Townsend, A.1    Bastin, J.2    Gould, K.3    Brownlee, G.4    Andrew, M.5    Coupar, B.6    Boyle, D.7    Chan, S.8    Smith, G.9
  • 53
    • 0030862430 scopus 로고    scopus 로고
    • Compact, synthetic, vaccinia virus early/late promoter for protein expression
    • Chakrabarti S, Sisler JR, Moss B. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23:1094-1097.
    • (1997) Biotechniques , vol.23 , pp. 1094-1097
    • Chakrabarti, S.1    Sisler, J.R.2    Moss, B.3
  • 54
    • 75249095378 scopus 로고    scopus 로고
    • Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines
    • Wang Z, Martinez J, Zhou W, La Rosa C, Srivastava T, Dasgupta A, Rawal R, Li Z, Britt WJ, Diamond D. 2010. Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines. Vaccine 28:1547-1557. http://dx.doi.org/10.1016/j.vaccine.2009.11.056.
    • (2010) Vaccine , vol.28 , pp. 1547-1557
    • Wang, Z.1    Martinez, J.2    Zhou, W.3    La Rosa, C.4    Srivastava, T.5    Dasgupta, A.6    Rawal, R.7    Li, Z.8    Britt, W.J.9    Diamond, D.10
  • 55
    • 0030446387 scopus 로고    scopus 로고
    • Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
    • Wyatt LS, Shors ST, Murphy BR, Moss B. 1996. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model. Vaccine 14:1451-1458. http://dx.doi.org/10.1016/S0264-410X(96)00072-2.
    • (1996) Vaccine , vol.14 , pp. 1451-1458
    • Wyatt, L.S.1    Shors, S.T.2    Murphy, B.R.3    Moss, B.4
  • 56
    • 79955939284 scopus 로고    scopus 로고
    • Dual neonate vaccine platform against HIV-1 and M. tuberculosis
    • Hopkins R, Bridgeman A, Joseph J, Gilbert SC, McShane H, Hanke T. 2011. Dual neonate vaccine platform against HIV-1 and M. tuberculosis. PLoS One 6:e20067. http://dx.doi.org/10.1371/journal.pone.0020067.
    • (2011) PLoS One , vol.6
    • Hopkins, R.1    Bridgeman, A.2    Joseph, J.3    Gilbert, S.C.4    McShane, H.5    Hanke, T.6
  • 57
    • 0346521283 scopus 로고    scopus 로고
    • Making sense of mass destruction: quantitating MHC class I antigen presentation
    • Yewdell JW, Reits E, Neefjes J. 2003. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3:952-961. http://dx.doi.org/10.1038/nri1250.
    • (2003) Nat Rev Immunol , vol.3 , pp. 952-961
    • Yewdell, J.W.1    Reits, E.2    Neefjes, J.3
  • 58
    • 0035500453 scopus 로고    scopus 로고
    • Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein
    • Khan S, de Giuli R, Schmidtke G, Bruns M, Buchmeier M, van den Broek M, Groettrup M. 2001. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol 167:4801-4804. http://dx.doi.org/10.4049/jimmunol.167.9.4801.
    • (2001) J Immunol , vol.167 , pp. 4801-4804
    • Khan, S.1    de Giuli, R.2    Schmidtke, G.3    Bruns, M.4    Buchmeier, M.5    van den Broek, M.6    Groettrup, M.7
  • 59
    • 77749249463 scopus 로고    scopus 로고
    • The synthesis of truncated polypeptides for immune surveillance and viral evasion
    • Cardinaud S, Starck SR, Chandra P, Shastri N. 2010. The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One 5:e8692. http://dx.doi.org/10.1371/journal.pone.0008692.
    • (2010) PLoS One , vol.5
    • Cardinaud, S.1    Starck, S.R.2    Chandra, P.3    Shastri, N.4
  • 60
    • 79951841879 scopus 로고    scopus 로고
    • Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance
    • Dolan BP, Li L, Veltri CA, Ireland CM, Bennink JR, Yewdell JW. 2011. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J Immunol 186:2065-2072. http://dx.doi.org/10.4049/jimmunol.1003096.
    • (2011) J Immunol , vol.186 , pp. 2065-2072
    • Dolan, B.P.1    Li, L.2    Veltri, C.A.3    Ireland, C.M.4    Bennink, J.R.5    Yewdell, J.W.6
  • 61
    • 79958766636 scopus 로고    scopus 로고
    • Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands
    • Dolan BP, Bennink JR, Yewdell JW. 2011. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci 68:1481-1489. http://dx.doi.org/10.1007/s00018-011-0656-z.
    • (2011) Cell Mol Life Sci , vol.68 , pp. 1481-1489
    • Dolan, B.P.1    Bennink, J.R.2    Yewdell, J.W.3
  • 62
    • 84899080404 scopus 로고    scopus 로고
    • The nature and extent of contributions by defective ribosome products to the HLA peptidome
    • Bourdetsky D, Schmelzer CE, Admon A. 2014. The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A 111:E1591-E1599. http://dx.doi.org/10.1073/pnas.1321902111.
    • (2014) Proc Natl Acad Sci U S A , vol.111 , pp. E1591-E1599
    • Bourdetsky, D.1    Schmelzer, C.E.2    Admon, A.3
  • 64
    • 79961016996 scopus 로고    scopus 로고
    • Major source of antigenic peptides for theMHCclass I pathway is produced during the pioneer round of mRNA translation
    • Apcher S, Daskalogianni C, Lejeune F, Manoury B, Imhoos G, Heslop L, Fahraeus R. 2011. Major source of antigenic peptides for theMHCclass I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A 108:11572-11577. http://dx.doi.org/10.1073/pnas.1104104108.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 11572-11577
    • Apcher, S.1    Daskalogianni, C.2    Lejeune, F.3    Manoury, B.4    Imhoos, G.5    Heslop, L.6    Fahraeus, R.7
  • 65
    • 84867655637 scopus 로고    scopus 로고
    • Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides
    • Farfan-Arribas DJ, Stern LJ, Rock KL. 2012. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides. Proc Natl Acad SciUS A 109:16998-17003. http://dx.doi.org/10.1073/pnas.1210271109.
    • (2012) Proc Natl Acad SciUS A , vol.109 , pp. 16998-17003
    • Farfan-Arribas, D.J.1    Stern, L.J.2    Rock, K.L.3
  • 66
    • 0029120173 scopus 로고
    • Rate of antigen degradation by the ubiquitin-proteasome pathway influencesMHCclass I presentation
    • Grant EP, Michalek MT, Goldberg AL, Rock KL. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influencesMHCclass I presentation. J Immunol 155:3750-3758.
    • (1995) J Immunol , vol.155 , pp. 3750-3758
    • Grant, E.P.1    Michalek, M.T.2    Goldberg, A.L.3    Rock, K.L.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.